[{"run_id":"20260906T231458-5fdd2fff","observed_at":"2026-09-06 23:14:58.172943+00:00","course_uid":"course_3fccebda183122da4a95adb6","course_id":"PHMSCI 770","catalog_version_id":"f6477f279dae5c75278010d122a5ffa7397ded5a5db8c1ec0a762d14306f6467","record_version_id":"3fe82b78da6106da037370637cb182711f649ef50c59fe8ba86c8554e0a230bf","job_id":"enrich-5291a20b802b9bbbe22b24cb","output_id":"84ab0836e30712e66a625cb48dcba1b03c7230972fb23a02ff5eefa7aadadc40","section":"requirements","status":"valid","value_json":"{\"nodes\":[{\"children\":[],\"condition\":\"Declared in MS Pharmaceutical Sciences\",\"course\":null,\"evidence\":\"Declared in MS Pharmaceutical Sciences\",\"id\":\"n0\",\"kind\":\"condition\"}],\"notes\":[],\"root\":\"n0\",\"status\":\"parsed\"}","candidate_json":null,"error":null,"model":"nvidia/Qwen3.6-35B-A3B-NVFP4","model_revision":"1355db6a052410cfd62085d94b58866fd0f2c3c5","selected_for_release":false},{"run_id":"20260906T231458-5fdd2fff","observed_at":"2026-09-06 23:14:58.172943+00:00","course_uid":"course_3fccebda183122da4a95adb6","course_id":"PHMSCI 770","catalog_version_id":"f6477f279dae5c75278010d122a5ffa7397ded5a5db8c1ec0a762d14306f6467","record_version_id":"3fe82b78da6106da037370637cb182711f649ef50c59fe8ba86c8554e0a230bf","job_id":"enrich-5291a20b802b9bbbe22b24cb","output_id":"84ab0836e30712e66a625cb48dcba1b03c7230972fb23a02ff5eefa7aadadc40","section":"search_profile","status":"valid","value_json":"{\"assumed_background\":[{\"evidence\":[{\"course_id\":\"PHMSCI 770\",\"field\":\"description\",\"quote\":\"Explores how chemical properties influence molecular targets in the central nervous system (CNS), how altered signaling drives physiological changes, and how cholinergic and glutamatergic pharmaceuticals improve patient outcomes.\"}],\"text\":\"Foundational knowledge in chemistry, molecular biology, and pharmacology related to the central nervous system.\"}],\"search_phrases\":[\"CNS drug design\",\"molecular targets central nervous system\",\"cholinergic glutamatergic pharmaceuticals\",\"primary literature analysis skills\",\"pharmaceutical sciences graduate course\"],\"skills_taught\":[{\"evidence\":[{\"course_id\":\"PHMSCI 770\",\"field\":\"description\",\"quote\":\"Develops skills in primary literature analysis to enable conceptual integration of information across chemical, molecular, cellular, systems, and societal levels.\"}],\"text\":\"Primary literature analysis and conceptual integration across multiple biological and chemical levels.\"}],\"summary\":{\"evidence\":[{\"course_id\":\"PHMSCI 770\",\"field\":\"title\",\"quote\":\"CNS DRUG DESIGNS, ACTIONS, AND APPLICATIONS I\"},{\"course_id\":\"PHMSCI 770\",\"field\":\"description\",\"quote\":\"Explores how chemical properties influence molecular targets in the central nervous system (CNS)\"}],\"text\":\"PHMSCI 770 explores chemical influences on CNS molecular targets and develops primary literature analysis skills.\"},\"topics\":[{\"evidence\":[{\"course_id\":\"PHMSCI 770\",\"field\":\"description\",\"quote\":\"chemical properties influence molecular targets in the central nervous system (CNS)\"}],\"text\":\"Chemical properties and molecular targets in the CNS\"},{\"evidence\":[{\"course_id\":\"PHMSCI 770\",\"field\":\"description\",\"quote\":\"altered signaling drives physiological changes\"}],\"text\":\"Altered signaling and physiological changes\"},{\"evidence\":[{\"course_id\":\"PHMSCI 770\",\"field\":\"description\",\"quote\":\"cholinergic and glutamatergic pharmaceuticals improve patient outcomes\"}],\"text\":\"Cholinergic and glutamatergic pharmaceuticals\"},{\"evidence\":[{\"course_id\":\"PHMSCI 770\",\"field\":\"description\",\"quote\":\"conceptual integration of information across chemical, molecular, cellular, systems, and societal levels\"}],\"text\":\"Conceptual integration across chemical, molecular, cellular, systems, and societal levels\"}]}","candidate_json":null,"error":null,"model":"nvidia/Qwen3.6-35B-A3B-NVFP4","model_revision":"1355db6a052410cfd62085d94b58866fd0f2c3c5","selected_for_release":false},{"run_id":"20260906T231458-5fdd2fff","observed_at":"2026-09-06 23:14:58.172943+00:00","course_uid":"course_3fccebda183122da4a95adb6","course_id":"PHMSCI 770","catalog_version_id":"f6477f279dae5c75278010d122a5ffa7397ded5a5db8c1ec0a762d14306f6467","record_version_id":"3fe82b78da6106da037370637cb182711f649ef50c59fe8ba86c8554e0a230bf","job_id":"enrich-5291a20b802b9bbbe22b24cb","output_id":"84ab0836e30712e66a625cb48dcba1b03c7230972fb23a02ff5eefa7aadadc40","section":"student_experience","status":"insufficient_evidence","value_json":"{\"status\":\"insufficient_evidence\",\"themes\":[]}","candidate_json":null,"error":null,"model":"nvidia/Qwen3.6-35B-A3B-NVFP4","model_revision":"1355db6a052410cfd62085d94b58866fd0f2c3c5","selected_for_release":false},{"run_id":"20260907T155543-ce3781c4","observed_at":"2026-09-07 15:55:43.033547+00:00","course_uid":"course_3fccebda183122da4a95adb6","course_id":"PHMSCI 770","catalog_version_id":"f6477f279dae5c75278010d122a5ffa7397ded5a5db8c1ec0a762d14306f6467","record_version_id":"3fe82b78da6106da037370637cb182711f649ef50c59fe8ba86c8554e0a230bf","job_id":"enrich-5590a4969e0a630fe46a86e8","output_id":"2eff4828e98fe29bcf7405044a6e700c9b3b7c355fd860d5a20e65e5db71a9f0","section":"requirements","status":"valid","value_json":"{\"nodes\":[{\"children\":[],\"condition\":\"Declared in MS Pharmaceutical Sciences\",\"course\":null,\"evidence\":\"Declared in MS Pharmaceutical Sciences\",\"id\":\"n0\",\"kind\":\"condition\"}],\"notes\":[],\"root\":\"n0\",\"status\":\"parsed\"}","candidate_json":null,"error":null,"model":"nvidia/Qwen3.6-35B-A3B-NVFP4","model_revision":"1355db6a052410cfd62085d94b58866fd0f2c3c5","selected_for_release":true},{"run_id":"20260907T155543-ce3781c4","observed_at":"2026-09-07 15:55:43.033547+00:00","course_uid":"course_3fccebda183122da4a95adb6","course_id":"PHMSCI 770","catalog_version_id":"f6477f279dae5c75278010d122a5ffa7397ded5a5db8c1ec0a762d14306f6467","record_version_id":"3fe82b78da6106da037370637cb182711f649ef50c59fe8ba86c8554e0a230bf","job_id":"enrich-5590a4969e0a630fe46a86e8","output_id":"2eff4828e98fe29bcf7405044a6e700c9b3b7c355fd860d5a20e65e5db71a9f0","section":"search_profile","status":"valid","value_json":"{\"assumed_background\":[{\"evidence\":[{\"course_id\":\"PHMSCI 770\",\"field\":\"description\",\"quote\":\"Explores how chemical properties influence molecular targets in the central nervous system (CNS), how altered signaling drives physiological changes, and how cholinergic and glutamatergic pharmaceuticals improve patient outcomes.\"}],\"text\":\"Foundational knowledge in chemistry, molecular biology, and pharmacology related to the central nervous system.\"}],\"search_phrases\":[\"CNS drug design\",\"molecular targets central nervous system\",\"cholinergic glutamatergic pharmaceuticals\",\"primary literature analysis skills\",\"pharmaceutical sciences graduate course\"],\"skills_taught\":[{\"evidence\":[{\"course_id\":\"PHMSCI 770\",\"field\":\"description\",\"quote\":\"Develops skills in primary literature analysis to enable conceptual integration of information across chemical, molecular, cellular, systems, and societal levels.\"}],\"text\":\"Primary literature analysis and conceptual integration across multiple biological and chemical levels.\"}],\"summary\":{\"evidence\":[{\"course_id\":\"PHMSCI 770\",\"field\":\"title\",\"quote\":\"CNS DRUG DESIGNS, ACTIONS, AND APPLICATIONS I\"},{\"course_id\":\"PHMSCI 770\",\"field\":\"description\",\"quote\":\"Explores how chemical properties influence molecular targets in the central nervous system (CNS)\"}],\"text\":\"PHMSCI 770 explores chemical influences on CNS molecular targets and develops primary literature analysis skills.\"},\"topics\":[{\"evidence\":[{\"course_id\":\"PHMSCI 770\",\"field\":\"description\",\"quote\":\"chemical properties influence molecular targets in the central nervous system (CNS)\"}],\"text\":\"Chemical properties and molecular targets in the CNS\"},{\"evidence\":[{\"course_id\":\"PHMSCI 770\",\"field\":\"description\",\"quote\":\"altered signaling drives physiological changes\"}],\"text\":\"Altered signaling and physiological changes\"},{\"evidence\":[{\"course_id\":\"PHMSCI 770\",\"field\":\"description\",\"quote\":\"cholinergic and glutamatergic pharmaceuticals improve patient outcomes\"}],\"text\":\"Cholinergic and glutamatergic pharmaceuticals\"},{\"evidence\":[{\"course_id\":\"PHMSCI 770\",\"field\":\"description\",\"quote\":\"conceptual integration of information across chemical, molecular, cellular, systems, and societal levels\"}],\"text\":\"Conceptual integration across chemical, molecular, cellular, systems, and societal levels\"}]}","candidate_json":null,"error":null,"model":"nvidia/Qwen3.6-35B-A3B-NVFP4","model_revision":"1355db6a052410cfd62085d94b58866fd0f2c3c5","selected_for_release":true},{"run_id":"20260907T155543-ce3781c4","observed_at":"2026-09-07 15:55:43.033547+00:00","course_uid":"course_3fccebda183122da4a95adb6","course_id":"PHMSCI 770","catalog_version_id":"f6477f279dae5c75278010d122a5ffa7397ded5a5db8c1ec0a762d14306f6467","record_version_id":"3fe82b78da6106da037370637cb182711f649ef50c59fe8ba86c8554e0a230bf","job_id":"enrich-5590a4969e0a630fe46a86e8","output_id":"2eff4828e98fe29bcf7405044a6e700c9b3b7c355fd860d5a20e65e5db71a9f0","section":"student_experience","status":"insufficient_evidence","value_json":"{\"status\":\"insufficient_evidence\",\"themes\":[]}","candidate_json":null,"error":null,"model":"nvidia/Qwen3.6-35B-A3B-NVFP4","model_revision":"1355db6a052410cfd62085d94b58866fd0f2c3c5","selected_for_release":true},{"run_id":"20260907T155543-ce3781c4","observed_at":"2026-09-07 15:55:43.033547+00:00","course_uid":"course_3fccebda183122da4a95adb6","course_id":"PHMSCI 770","catalog_version_id":"f6477f279dae5c75278010d122a5ffa7397ded5a5db8c1ec0a762d14306f6467","record_version_id":"3fe82b78da6106da037370637cb182711f649ef50c59fe8ba86c8554e0a230bf","job_id":"enrich-8b774950c2b6adfdc46d1b82","output_id":"41c10563bfd85720fba04cad3d0937cc8ff27bc1ad8ba38ac070a0d75ede1639","section":"requirements","status":"valid","value_json":"{\"nodes\":[{\"children\":[],\"condition\":\"Declared in MS Pharmaceutical Sciences\",\"course\":null,\"evidence\":\"Declared in MS Pharmaceutical Sciences\",\"id\":\"n0\",\"kind\":\"condition\"}],\"notes\":[],\"root\":\"n0\",\"status\":\"parsed\"}","candidate_json":null,"error":null,"model":"nvidia/Qwen3.6-35B-A3B-NVFP4","model_revision":"1355db6a052410cfd62085d94b58866fd0f2c3c5","selected_for_release":true},{"run_id":"20260907T155543-ce3781c4","observed_at":"2026-09-07 15:55:43.033547+00:00","course_uid":"course_3fccebda183122da4a95adb6","course_id":"PHMSCI 770","catalog_version_id":"f6477f279dae5c75278010d122a5ffa7397ded5a5db8c1ec0a762d14306f6467","record_version_id":"3fe82b78da6106da037370637cb182711f649ef50c59fe8ba86c8554e0a230bf","job_id":"enrich-8b774950c2b6adfdc46d1b82","output_id":"41c10563bfd85720fba04cad3d0937cc8ff27bc1ad8ba38ac070a0d75ede1639","section":"search_profile","status":"valid","value_json":"{\"assumed_background\":[{\"evidence\":[{\"course_id\":\"PHMSCI 770\",\"field\":\"description\",\"quote\":\"Explores how chemical properties influence molecular targets in the central nervous system (CNS), how altered signaling drives physiological changes, and how cholinergic and glutamatergic pharmaceuticals improve patient outcomes.\"}],\"text\":\"Foundational knowledge in chemistry, molecular biology, and pharmacology related to the central nervous system.\"}],\"search_phrases\":[\"CNS drug design\",\"molecular targets central nervous system\",\"cholinergic glutamatergic pharmaceuticals\",\"primary literature analysis skills\",\"pharmaceutical sciences graduate course\"],\"skills_taught\":[{\"evidence\":[{\"course_id\":\"PHMSCI 770\",\"field\":\"description\",\"quote\":\"Develops skills in primary literature analysis to enable conceptual integration of information across chemical, molecular, cellular, systems, and societal levels.\"}],\"text\":\"Primary literature analysis and conceptual integration across multiple biological and chemical levels.\"}],\"summary\":{\"evidence\":[{\"course_id\":\"PHMSCI 770\",\"field\":\"title\",\"quote\":\"CNS DRUG DESIGNS, ACTIONS, AND APPLICATIONS I\"},{\"course_id\":\"PHMSCI 770\",\"field\":\"description\",\"quote\":\"Explores how chemical properties influence molecular targets in the central nervous system (CNS)\"}],\"text\":\"PHMSCI 770 explores chemical influences on CNS molecular targets and develops primary literature analysis skills.\"},\"topics\":[{\"evidence\":[{\"course_id\":\"PHMSCI 770\",\"field\":\"description\",\"quote\":\"chemical properties influence molecular targets in the central nervous system (CNS)\"}],\"text\":\"Chemical properties and molecular targets in the CNS\"},{\"evidence\":[{\"course_id\":\"PHMSCI 770\",\"field\":\"description\",\"quote\":\"altered signaling drives physiological changes\"}],\"text\":\"Altered signaling and physiological changes\"},{\"evidence\":[{\"course_id\":\"PHMSCI 770\",\"field\":\"description\",\"quote\":\"cholinergic and glutamatergic pharmaceuticals improve patient outcomes\"}],\"text\":\"Cholinergic and glutamatergic pharmaceuticals\"},{\"evidence\":[{\"course_id\":\"PHMSCI 770\",\"field\":\"description\",\"quote\":\"conceptual integration of information across chemical, molecular, cellular, systems, and societal levels\"}],\"text\":\"Conceptual integration across chemical, molecular, cellular, systems, and societal levels\"}]}","candidate_json":null,"error":null,"model":"nvidia/Qwen3.6-35B-A3B-NVFP4","model_revision":"1355db6a052410cfd62085d94b58866fd0f2c3c5","selected_for_release":true},{"run_id":"20260907T155543-ce3781c4","observed_at":"2026-09-07 15:55:43.033547+00:00","course_uid":"course_3fccebda183122da4a95adb6","course_id":"PHMSCI 770","catalog_version_id":"f6477f279dae5c75278010d122a5ffa7397ded5a5db8c1ec0a762d14306f6467","record_version_id":"3fe82b78da6106da037370637cb182711f649ef50c59fe8ba86c8554e0a230bf","job_id":"enrich-8b774950c2b6adfdc46d1b82","output_id":"41c10563bfd85720fba04cad3d0937cc8ff27bc1ad8ba38ac070a0d75ede1639","section":"student_experience","status":"insufficient_evidence","value_json":"{\"status\":\"insufficient_evidence\",\"themes\":[]}","candidate_json":null,"error":null,"model":"nvidia/Qwen3.6-35B-A3B-NVFP4","model_revision":"1355db6a052410cfd62085d94b58866fd0f2c3c5","selected_for_release":true},{"run_id":"20260907T155543-ce3781c4","observed_at":"2026-09-07 15:55:43.033547+00:00","course_uid":"course_3fccebda183122da4a95adb6","course_id":"PHMSCI 770","catalog_version_id":"f6477f279dae5c75278010d122a5ffa7397ded5a5db8c1ec0a762d14306f6467","record_version_id":"3fe82b78da6106da037370637cb182711f649ef50c59fe8ba86c8554e0a230bf","job_id":"enrich-8b774950c2b6adfdc46d1b82","output_id":"41c10563bfd85720fba04cad3d0937cc8ff27bc1ad8ba38ac070a0d75ede1639","section":"student_summary","status":"valid","value_json":"{\"context_hash\":\"9a97bb3d285919998e20fc646656172f816c90fd7c21d57e51300569ac361489\",\"course_id\":\"PHMSCI 770\",\"current_instructors\":[{\"instructor_uid\":\"instructor_4665262be09bc2f212f8530f\",\"message\":\"No course-specific reviews available\",\"name\":\"Charles Lauhon\",\"review_status\":\"no_course_reviews\",\"rmp_instructor_id\":null,\"summary\":[]},{\"instructor_uid\":\"instructor_c542cb2db8a9ed5e1f19d360\",\"message\":\"No course-specific reviews available\",\"name\":\"Cody Wenthur\",\"review_status\":\"no_course_reviews\",\"rmp_instructor_id\":null,\"summary\":[]},{\"instructor_uid\":\"instructor_8b93b1a07597494f4dccd540\",\"message\":\"No course-specific reviews available\",\"name\":\"Zachary Del Mundo\",\"review_status\":\"no_course_reviews\",\"rmp_instructor_id\":null,\"summary\":[]}],\"difficulty_workload\":[],\"errors\":[],\"historical_context\":[],\"message\":\"No course-specific reviews available\",\"offered\":true,\"profile_hash\":\"5cb4dabf887cdbcd8c00d5a1312e10828b95c63f30bc3ea76aea199565390d02\",\"quick_take\":[{\"citations\":[{\"course_id\":\"PHMSCI 770\",\"run_id\":\"20260907T155543-ce3781c4\",\"source_record\":{\"entity_id\":\"ee8e37bd-e595-3df5-a266-87f2b3460a8a\",\"file\":\"tables/observations.parquet\",\"kind\":\"grades\",\"source\":\"madgrades\"},\"table\":\"grades_latest\",\"term_id\":\"1074\",\"type\":\"grade\"}],\"text\":\"Recent recorded grades — Spring 2007: 3.77 GPA, 92.3% A/AB (n=13 letter grades).\"}],\"student_experience\":[],\"task_hash\":\"74fb0997943e888960bbc9e47db8c4fd12e4292d55c20509d8d89db6a9910f68\",\"teaching_history\":[],\"term_id\":\"1272\",\"term_name\":\"2026 Fall\",\"version\":2}","candidate_json":null,"error":null,"model":"nvidia/Qwen3.6-35B-A3B-NVFP4","model_revision":"1355db6a052410cfd62085d94b58866fd0f2c3c5","selected_for_release":true}]